Travere Therapeutics(TVTX) - 2022 Q4 - Earnings Call Transcript

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Naomi Eichenbaum - VP, IR Eric Dube - President, CEO & Director Jula Inrig - Chief Medical Officer Christopher Cline - CFO Peter Heerma - Chief Commercial Officer William Rote - SVP, Research & Development Conference Call Participants Gregory Harrison - Bank of America Merrill Lynch Maurice Raycroft - Jefferies Joseph Schwartz - SVB Securities Lachlan Hanbury-Brown - William Blair & Co ...